跳至主要内容
临床试验/DRKS00014265
DRKS00014265招募中未知

Selective depletion of C-reactive protein by means of therapeutic apheresis (CRP-apheresis) in acute pancreatitis - CAPRI1

Pentracor GmbH0 个研究点目标入组 20 人开始时间: 2018年3月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Acute pancreatitis according to the S3 Guideline Pancreatitis of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
  • Moderate or severe acute pancreatitis according to the Atlanta Classification of 2013
  • CRP = 100 mg/l up to 24 hours after symptom onset or CRP = 150 mg/l if the onset of symptoms was more than 24 hours ago
  • Written informed consent

排除标准

  • Age < 18 or = 80 years
  • Positive harmless acute pancreatitis score (HAPS)
  • Therapy-refractory shock
  • Pregnancy or breastfeeding
  • Participation in other interventional trials

研究者

发起方
Pentracor GmbH

相似试验